Back to TSHA
GOLDMAN SACHS GROUP INC → TSHA
GOLDMAN SACHS GROUP INC TSHA Position History
Taysha Gene Therapies, Inc. • Healthcare
Quarters held
13
Latest value
$78K
Q2 2026
Peak value
$92.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $28.9M |
| Q2 2025 | $140K |
| Q3 2025 | $43.2M |
| Q3 2025 | $589K |
| Q4 2025 | $1.3M |
| Q4 2025 | $74M |
| Q4 2025 | $74M |
| Q4 2025 | $1.3M |
| Q1 2026 | $59.3M |
| Q1 2026 | $40.7M |
| Q2 2026 | $92.5M |
| Q2 2026 | $62.1M |
| Q2 2026 | $78K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $78K | 11.4K | — | — |
| Q2 2026 | $62.1M | 9.12M | — | — |
| Q2 2026 | $92.5M | 13.58M | — | — |
| Q1 2026 | $40.7M | 9.10M | — | — |
| Q1 2026 | $59.3M | 13.27M | — | — |
| Q4 2025 | $1.3M | 237.9K | — | — |
| Q4 2025 | $74M | 13.45M | — | — |
| Q4 2025 | $74M | 13.45M | — | — |
| Q4 2025 | $1.3M | 237.9K | — | — |
| Q3 2025 | $589K | 180.0K | — | — |
| Q3 2025 | $43.2M | 13.20M | — | — |
| Q2 2025 | $140K | 60.7K | — | — |
| Q2 2025 | $28.9M | 12.53M | — | — |
Other funds holding TSHA
$109M
$88M
$77.8M
$77.8M
$73.4M
$53.7M
$50.1M